Immunopathogenesis of Pneumocystis carinii pneumonia

Expert Reviews in Molecular Medicine

Volumn 7, Issue 26, 2005, Pages

  Gigliotti, Francis ^a   Wright, Terry W ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

Inflammation; Lung injury; Pathogenesis; Pneumocystis carinii; Pneumonia

Indexed keywords

ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; LUNG SURFACTANT; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BACTERIAL COUNT; CANCER PATIENT; CELLULAR IMMUNITY; CLINICAL TRIAL; CORRELATION FUNCTION; DATA ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; EXPERIMENTATION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; LUNG ALVEOLUS MACROPHAGE; LUNG INJURY; MORBIDITY; MORTALITY; NEUTROPHIL; NONHUMAN; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TREATMENT PLANNING; AIDS RELATED COMPLEX; ANIMAL; ANIMAL DISEASE; CLASSIFICATION; IMMUNOLOGY; INFANT; LUNG COMPLIANCE; MAMMAL; METABOLISM; MICROBIOLOGY; MOUSE; MOUSE MUTANT; PATHOGENICITY; PHYSIOLOGY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTOSIS; SPECIES DIFFERENCE; T LYMPHOCYTE SUBPOPULATION;

BACTERIA (MICROORGANISMS); HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS; PNEUMOCYSTIS CARINII;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; IMMUNOCOMPROMISED HOST; INFANT; INFLAMMATION; LUNG COMPLIANCE; MACROPHAGES, ALVEOLAR; MAMMALS; MICE; MICE, SCID; NEUTROPHILS; PNEUMOCYSTIS INFECTIONS; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS; PULMONARY SURFACTANTS; SIGNAL TRANSDUCTION; SPECIES SPECIFICITY; T-LYMPHOCYTE SUBSETS;

EID: 31044434667     PISSN: 14623994     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1462399405010203     Document Type: Review

References (85)

1. Peglow, S.L. et al. (1990) Serologic responses to Pneumocysfis carinii antigens in health and disease. J Infect Dis 161, 296-306,
2. Vargas, S.L. et al. (2001) Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis 32, 855-861,
3. Gigliotti, F., Harmsen, A.G. and Wright, T.W. (2003) Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB / c mice. Infect Immun 71, 3852-3856,
4. Gigliotti, F. and Haidaris, C.G. (1998) Antigenic characterization of Pneumocystis carinii. Semin Respir Infect 13, 313-322,
5. Gigliotti, F. et al. (1993) Pneumocystis carinii is not universally transmissible between mammalian species. Infect Immun 61, 2886-2890,
6. Stringer, J.R., Cushion, M.T. and Wakefield, A.E. (2001) New nomenclature for the genus Pneumocystis. J Eukaryot Microbiol Suppl, 184S-189S,
7. Stringer, J.R. et al. (2002) A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 8, 891-896,
8. Hughes, W.T. (2003) Pneumocystis carinii vs. Pneumocystis jiroveci: another misnomer (response to Stringer et al.). Emerg Infect Dis 9, 276-277; author reply 277-279,
9. Gigliotti, F. Pneumocystis carinii: has the name really been changed? Clin Infect Dis (in press)
10. Meuwissen, J.H. (1976) Infections with Pneumocystis carinii. Natl Cancer Inst Monogr 43, 133-136,
11. Vargas, S.L. et al. (1999) Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin Infect Dis 29, 1489-1493,
12. Morgan, D.J. et al. (2001) Identification of Pneumocystis carinii in the lungs of infants dying of sudden infant death syndrome.Pediatr Infect Dis J 20, 306-309,
13. Durand-Joly, J. et al. (2002) Pneumocystis carinii f. sp. hominis is not infectious for SCID mice. J Clin Microbiol 40, 1862-1865,
14. Chen, W., Gigliotti, F. and Harmsen, A.G. (1993) Latency is not an inevitable outcome of infection with Pneumocystis carinii.Infect Immun 61, 5406-5409,
15. Vargas, S.L. et al. (1995) Limited persistence in and subsequent elimination of Pneumocystis carinii from the lungs after P. carinii pneumonia. J Infect Dis 172,506-510,
16. Keely, S.P. et al. (1995) Genetic variation among Pneumocystis carinii hominis isolates in recurrent pneumocystosis. J Infect Dis 172, 595-598,
17. Tsolaki, A.G. et al. (1996) Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia. J Infect Dis 174, 141-156,
18. Russian, D.A. and Levine, S.J. (2001) Pneumocystis carinii pneumonia in patients without HIV infection. Am J Med Sci 321,56-65,
19. Kovacs, J.A. et al. (1984) Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100, 663-671,
20. Mansharamani, N.G. et al. (2000) Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest 118, 704-711,
21. Ward, M.M. and Donald, F. (1999) Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum 42, 780789,
22. Bachelez, H. et al. (1997) Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositis. Arch Intern Med 157, 1501-1503,
23. Ziefer, A. and Abramowitz, J.A. (1989) Pneumocystis carinii pneumonia in HIV-positive and HIV-negative patients. An epidemiological, clinical and histopathological study of 18 patients. S Afr Med J 76, 308-313,
24. Roths, J.B. and Sidman, C.L. (1992) Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice. J Clin Invest 90, 673-678,
25. Wright, T.W. et al. (1997) Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am J Respir Cell Mol Biol 17, 491-500,
26. Wright, T.W. et al. (1999) Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect Immun 67, 3452-3460,
27. Wright, T.W. et al. (1999) Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest 104, 1307-1317,
28. Shellito, J.E. et al. (2000) Murine CD4+ T lymphocyte subsets and host defense against Pneumocystis carinii. J Infect Dis 181, 2011-2017,
29. Garvy, B.A. et al. (1997) Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect Immun 65, 5052-5056,
30. Wright, T.W. et al. (2004) TNF receptor signaling contributes to chemokine secretion, inflammation, and respiratory deficits during Pneumocystis pneumonia. J Inummol 172, 2511-2521,
31. Kolls, J.K. et al. (1999) IFN-gamma and CD8+ T cells restore host defenses against Pneumocystis carinii in mice depleted of CD4+ T cells. J Immunol 162, 2890-2894,
32. McAllister, F. et al. (2004) T cytotoxic-1 CD8+ T cells are effector cells against pneumocystis in mice. J Immunol 172, 1132-1138,
33. Wu, A.K. et al. (2004) The unmasking of Pneumocystis jiroveci pneumonia during reversal of immunosuppression: case reports and literature review. BMC Infect Dis 4, 57,
34. Koval, C.E. et al. (2002) Immune reconstitution syndrome after successful treatment of Pneumocystis carind pneumonia in a man with human immunodeficiency virus type 1 infection. Clin Infect Dis 35, 491-493,
35. Hori, S., Carvalho, T.L. and Demengeot, J. (2002) CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol 32, 1282-1291,
36. Limper, A.H. et al. (1989) Pneumocystis carinii Pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 140, 1204-1209,
37. Benfield, T.L. et al. (1995) Prognostic value of interleukin-8 in AIDS-associated Pneumocystis carinii pneumonia. Am J Respir Crit Care Med 151, 1058-1062,
38. Sadaghdar, H., Huang, Z.B. and Eden, E. (1992) Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS. Evidence for the development of high-permeability pulmonary edema. Chest 102, 63-69,
39. Garvy, B.A., Gigliotti, F. and Harmsen, A.G. (1997) Neutralization of interferon-gamma exacerbates pneumocystis-driven interstitial pneumonitis after bone marrow transplantation in mice. J Clin Invest 99, 1637-1644,
40. Ruan, S. et al. (2002) Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection. Infect Immun 70, 6107-6113,
41. Swain, S.D. et al. (2004) Neither neutrophils nor reactive oxygen species contribute to tissue damage during Pneumocystis pneumonia in mice. Infect Immun 72, 5722-5732,
42. Chen, W. et al. (1992) Interleukin 1: an important mediator of host resistance against Pneumocystis carinii. J Exp Med 176, 713-718,
43. Chen, W, Havell, E.A. and Harmsen, A.G. (1992) Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection. Infect Immun 60, 1279-1284,
44. Krishnan, V.L. et al. (1990) Alveolar macrophages in AIDS patients: increased spontaneous tumour necrosis factor-alpha production in Pneumocystis cariiiii pneumonia. Clin Exp Immunol 80, 156-160,
45. Hoffman, O.A., Standing, J.E. and Limper, A.H. (1993) Pneumocystis carinii stimulates tumor necrosis factor-alpha release from alveolar macrophages through a beta-glucan-mediated mechanism. J Immunol 150, 3932-3940,
46. Kolls, J.K. et al. (1993) Alveolar macrophage release of tumor necrosis factor during murine Pneumocystis carinii pneumonia. Am J Respir Cell Mol Biol 8, 370-376,
47. Vassallo, R., Standing, J.E. and Limper, A.H. (2000) Isolated Pneumocystis carinii cell wall glucan provokes lower respiratory tract inflammatory responses. J Immunol 164, 3755-3763,
48. Laursen, A.L. et al. (1994) Pneumocystis carinii-induced activation of the respiratory burst in human monocytes and macrophages. Clin Exp Immunol 98, 196-202,
49. Ishimine, T. et al. (1995) Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii. Microbiol Immunol 39, 49-58,
50. Downing, J.F. et al. (1999) Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms, Infect Immun 67, 1347-1352,
51. Benfield, T.L. et al. (1995) Interleukin-8 and eicosanoid production in the lung during moderate to severe Pneumocystis carinii pneumonia in AIDS: a role of interleukin-8 in the pathogenesis of P. carinii pneumonia. Respir Med 89, 285-290,
52. Benfield, T.L. et al. (1997) The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes. Infect Immun 65, 4790-4794,
53. Benfield, T.L. et al. (1999) Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-1 release from a human alveolar epithelial cell line. Eur J Clin Invest 29, 717-722,
54. Lebron, F. et al. (2003) Pneumocystis carinii cell wall beta-glucans initiate macrophage inflammatory responses through NF-kappaB activation. J Biol Chem 278, 25001-25008,
55. Steele, C. et al. (2003) Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J Exp Med 198, 1677-1688,
56. Zhang, J. et al. (2004) Pneumocystis activates human alveolar macrophage NF-kappaB signaling through mannose receptors. Infect Immun 72, 3147-3160,
57. Evans, S.E. et al. (2005) Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms. Am J Respir Cell Mol Biol 32,490-497,
58. Wang, J. et al. (2005) Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect Immun 73, 2766-2777,
59. Kolls, J.K. et al. (1997) Exacerbation of murine Pneumocystis carinii infection by adenoviral-mediated gene transfer of a TNF inhibitor. Am J Respir Cell Mol Biol 16, 112-118,
60. Meissner, NX et al. (2005) Role of type I IFNs in pulmonary complications of Pneumocystis murina infection. J Immunol 174, 5462-5471,
61. Chen, W. et al. (1993) Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect Immun 61, 97-102,
62. Qureshi, M.H., Harmsen, A.G. and Garvy, B.A. (2003) IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J Immunol 170, 1002-1009,
63. Garvy, B.A., Ezekowitz, R.A. and Harmsen, A.G. (1997) Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect Immun 65, 373-379,
64. Ulich, T.R. et al. (1991) Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 138, 1097-1101,
65. Pottratz, S.T., Reese, S. and Sheldon, J.L. (1998) Pneumocystis carinii induces interleukin 6 production by an alveolar epithelial cell line. Eur J Clin Invest 28, 424-429,
66. Atochina, E.N. et al. (2004) Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 72, 6002-6011,
67. Atochina, E.N. et al. (2004) Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J Infect Dis 189, 1528-1539,
68. Linke, M. et al. (2005) Surfactant protein A limits Pneumocystis murina infection in immunosuppressed C3H/HeN mice and modulates host response during infection. Microbes Infect 7, 748-759,
69. O'Riordan, D.M. et al. (1995) Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 95, 2699-2710,
70. Yong, S.J. et al. (2003) Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun 71, 1662-1671,
71. Armstrong, L. et al. (2004) Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells. Am J Respir Cell Mol Biol 31, 241-245,
72. Wright, T.W. et al. (2001) Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.Infect Immun 69, 758-764,
73. Wang, Z. et al. (2005) Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro. Am J Physiol Lung Cell Mol Physiol 288, L1124-1131,
74. Nogee, L.M. et al. (1994) A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 93, 1860-1863,
75. Beers, M.F. et al. (1999) Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. J Lab Clin Med 133, 423-433,
76. Atochina, E.N. et al. (2000) P. carinii induces selective alterations in component expression and biophysical activity of lung surfactant. Am J Physiol Lung Cell Mol Physiol 278, L599-609,
77. Benfield, T.L. et al. (1997) Alveolar damage in AIDS-related Pneumocystis carinii pneumonia. Chest 111, 1193-1199,
78. Weber, W.R., Askin, F.B. and Dehner, L.P. (1977) Lung biopsy in Pneumocystis carinii pneumonia: a histopathologic study of typical and atypical features. Am J Clin Pathol 67, 11-19,
79. Simpson-Haidaris, P.J. et al. (1998) Induction of fibrinogen expression in the lung epithelium during Pneumocysfis carinii pneumonia. Infect Immun 66, 4431-4439,
80. Guadiz, G. et al. (1997) Polarized secretion of fibrinogen by lung epithelial cells. Am J Respir Cell Mol Biol 17, 60-69,
81. Sanyal, S.K. et al. (1981) Course of pulmonary dysfunction in children surviving Pneumocystis carinii pneumonifis. A prospective study. Am Rev Respir Dis 124, 161-166,
82. Suffredini, A.F. et al. (1986) Long-term prognosis of survivors of Pneumocystis carinii pneumonia. Structural and functional correlates. Chest 89, 229-233,
83. Suffredini, A.F. et al. (1990) Consensus statement on the use of corticosteroids; as adjunctive therapy for pneurnocystis pneumonia in the acquired immunodeficiency syndrome. The National Institutes of Health-University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Pneumonia. N Engl J Med 323, 1500-1504,
84. Creery, W.D. et al. (1997) Surfactant therapy improves pulmonary function in infants with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome. Pediatr Pulmonol 24, 370-373,
85. Herting, E. et al. (2002) Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr 91, 1174-1178,